HIGHLIGHTS
- who: Santos Castau00f1eda from the Rheumatology Division, Hospital de La Princesa, IIS-Princesa, Universidad Autu00f3noma de Madrid (UAM), Madrid, Spain have published the paper: Tocilizumab for the treatment of adult-onset Stillu2019s disease, in the Journal: (JOURNAL)
- what: M Overall, and despite not being approved yet by the regulatory authorities, based on the ed data shown in the different studies mentioned in this review, we conclude that TCZ is an effective drug for the overall management of AOSD, both for systemic and joint ce pt manifestations, as well as for some severe complications of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.